TREACE JOHN T. (Chief Executive Officer) purchased 2.2% of their position (153.76K shares) of TREACE MEDICAL CONCEPTS, INC. on the open market
Open‑market purchase worth $375.5K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 5/14/2026ACC: 0001193125-26-224391
DirectorOfficer10% Owner· Chief Executive Officer
Since Apr 2021
+153.76K
Net shares
Net buyer
$375.5K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
153.76K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+43K
Price / share
$2.17
Trade value
$93.48K
% of position
0.6%
5/12/2026
7M→7.05M
Common Stock
Direct
Shares
+49.01K
Price / share
$2.46
Trade value
$120.53K
% of position
0.7%
5/13/2026
7.05M→7.10M
Common Stock
Direct
Shares
+61.75K
Price / share
$2.62
Trade value
$161.49K
% of position
0.9%
5/14/2026
7.10M→7.16M
Total
Net shares
+153.76K
Net value
$375.51K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/12/2026 | P · Purchase | +43K | $2.17 | $93.48K | 0.6% | 7M | 7.05M |
| Common Stock Direct | 5/13/2026 | P · Purchase | +49.01K | $2.46 | $120.53K | 0.7% | 7.05M | 7.10M |
| Common Stock Direct | 5/14/2026 | P · Purchase | +61.75K | $2.62 | $161.49K | 0.9% | 7.10M | 7.16M |
| Total | +153.76K | $375.51K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned1.60M
Common Stock
IndirectShares owned408.82K
Common Stock
IndirectShares owned1.47M
Common Stock
IndirectShares owned1.84M
Total
5.32M indirect5.32M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.60M | Indirect |
| Common Stock | 408.82K | Indirect |
| Common Stock | 1.47M | Indirect |
| Common Stock | 1.84M | Indirect |
| Total | 5.32M | 5.32M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported